Skip to Main Content

Paper Details

Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study.
Diabetes Care
12
2021
-cell, Diabetes, HDL-cholesterol, HbA1c, Patient, T2D, Type 2 Diabetes, cholesterol, diabetes, glucagon, glucagon-like peptide 1, glucose, insulin, patients, polygenic, triglycerides, type 2 diabetes
Author NameAffiliation
Inês BarrosoResearch Centre for Optimal Health, University of Westminster
Jane KayeUniversity of Oxford
Jane KayeUniversity of Melbourne
Andrew T HattersleyInstitute of Biomedical and Clinical Science, University of Exeter Medical School
Andrew T HattersleyRoyal Devon and Exeter NHS Foundation Trust
Martin Ridderstråle
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
S??ren BrunakNovo Nordisk Foundation Center for Protein Research, University of Copenhagen
S??ren BrunakCenter for Biological Sequence Analysis, Technical University of Denmark
S??ren BrunakNovo Nordisk Foundation Center for Protein Research, University of Copenhagen
S??ren BrunakCenter for Biological Sequence Analysis, Technical University of Denmark
Ana ViñuelaUniversity of Geneva Medical School
Ana ViñuelaBiosciences Institute, Newcastle University
Anubha MahajanUniversity of Oxford
Emmanouil T DermitzakisUniversity of Geneva Medical School
Emmanouil T DermitzakisUniversity of Geneva Medical School
Timothy M FraylingUniversity of Oxford
Timothy M FraylingOxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
Timothy M FraylingUniversity of Oxford
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Jochen M SchwenkKTH Royal Institute of Technology
Jochen M SchwenkKTH Royal Institute of Technology
Paul W FranksLund University Diabetes Centre, Clinical Research Centre, Lund University, Skane University Hospital
Mark WalkerTranslational and Clinical Research Institute, Newcastle University
  • 1 - 24

Datasets